“…As mammography has limitations in detecting cancers that are hidden within the dense fibroglandular tissue, there is a need for an adjunctive screening device, which should be automated, user-friendly, acceptable to the patient, reproducible, and reliable (5,6). The results of a multicenter trial (7) using a supplemental screening breast ultrasound (US) for women at high risk with dense breast tissue have been promising; however, those results are plagued by a lack of reproducibility regarding lesion characterization, particularly for small lesions (8)(9)(10)(11)(12).…”